MedTrace Logo

MALE HAIR LOSS - Treatment With Dutasteride Mesotherapy x Dutasteride MMP Technique (Injections With Tattoo Machine)

NCT06110377 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-11-01

No results posted yet for this study

Summary

This randomized clinical trial carried out on 60 Brazilian men, aged 18 to 65, with mild or moderate androgenetic alopecia. Two techniques for administering dutasteride will be compared, injected by syringes or needles or by needling through tattoo machines.

Conditions

  • Androgenic Alopecia

Interventions

PROCEDURE

MESOTHERAPY (INJECTIONS WITH SYRINGE AND NEEDLE)

After the anesthetic block, dutasteride will be injected using syringes and needles into the area of alopecia.

PROCEDURE

MMP (INJECTIONS WITH A TATTOO MACHINE)

After the anesthetic block, dutasteride will be injected through needling performed by a tattoo machine in the area of alopecia.

Sponsors & Collaborators

  • Clinica Dermatologica Arbache ltda

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-30
Primary Completion
2024-04-01
Completion
2025-04-02

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06110377 on ClinicalTrials.gov